Pirtobrutinib FDA approval date

The FDA approved Pirtobrutinib (JAYPIRCA) on 27 Jan 2023.

FDA approval date
27 Jan 2023

Drug identity checked against registry records

Also recorded as JAYPIRCA

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLLNCT07516093NRIXPhase 3Recruiting2029-10Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-01-27DayPirtobrutinibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA216059", "applicant_as_listed_by_fda": "LOXO ONCOL", "brand_names": ["JAYPIRCA"], "active_ingredients": ["PIRTOBRUTINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230127", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026